Showing 361-370 of 5598 results for "".
Does PTSD Have the Wrong Name?
https://reachmd.com/programs/clinicians-roundtable/does-ptsd-have-the-wrong-name/1300/Host Dr. Leslie Lundt welcomes Dr. J. Alexander Bodkin, chief of the Clinical Psychopharmacology Research Program at the McLean Hospital and assistant professor in the department of psychiatry at Harvard Medical School. He discusses his latest work researching post traumatic stress disorder— a condiNavigating the Complexities of Small Intestinal Bacterial Overgrowth
https://reachmd.com/programs/gi-insights/navigating-the-complexities-of-small-intestinal-bacterial-overgrowth/12516/There are several challenges when it comes to testing for and treating small intestinal bacterial overgrowth, but there are ways we can combat them.The Interstate Compact: Toward Medical Licensure Portability Nationwide
https://reachmd.com/programs/conversations-on-health-care/the-interstate-compact-toward-medical-licensure-portability-nationwide/7030/This week, Mark and Margaret speak with Dr. Humayun Chaudhry, President and CEO of the Federation of State Medical Boards. Dr. Chaudhry has been working to advance the proposed Interstate Compact, a new option for medical licensing that would speed up the process of issuing licenses for physicians wEvaluating High-Flow Nasal Cannula in Acute Hypercapnic Respiratory Failure
https://reachmd.com/programs/clinicians-roundtable/high-flow-nasal-cannula-acute-hypercapnic-failure/54226/Navigating mCRPC Treatment: A Look at Abiraterone and Enzalutamide
https://reachmd.com/programs/project-oncology/navigating-mcrpc-treatment-a-look-at-abiraterone-and-enzalutamide/28644/Explore the efficacy of abiraterone and enzalutamide in treating metastatic castration-resistant prostate cancer.Navigating Treatment Choices for DMD: Key Factors to Consider
https://reachmd.com/programs/neurofrontiers/navigating-treatment-choices-for-dmd-key-factors-to-consider/26388/What are the key considerations when choosing treatment Duchenne muscular dystrophy? Find out here.Safety First: Navigating CELMoD-Associated Toxicities
https://reachmd.com/programs/cme/safety-first-navigating-celmod-associated-toxicities/36571/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityRadiation Nation: The Effects of Cell Phones on Children's Brains
https://reachmd.com/programs/primary-care-today/radiation-nation-effects-cell-phones-childrens-brains/9659/Daniel Debaun explains how radiation from cell phones can be damaging to children's developing brain.The Politics of Measles: Ethical Considerations in the National Vaccination Debate
https://reachmd.com/programs/primary-care-today/politics-measles-ethical-considerations-national-vaccination-debate/7297/The controversy over vaccinations and whether or not to regulate their administration has reached a boiling point in the United States with the recent measles outbreak originating in Disneyland, and prominent politicians like Senator Rand Paul and Governor Chris Christie have weighed in to support tNavigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study
https://reachmd.com/programs/medical-industry-feature/igan-pathogenesis-april-4-hit-process-patient-case-study/29535/In IgA nephropathy (IgAN), patients have a high burden of kidney disease at diagnosis, often presenting with chronic kidney disease stage ≥3.1-3 Early recognition is critical for management. That’s why Dr. Abby Yancey and Dr. Kartik Kalra explore IgAN’s underlying pathogenesis, heterogeneity in init